Drug Approval | November 09, 2022
The company currently supplies one product to the US market that contributes low- single digit revenue to Jubilant Pharmova revenue
CEPI will provide up to US$40 million in initial funding to support the development of mRNA-vaccine candidates against Lassa Fever virus
CGHS would give robust coverage to pensioners and with new innovations and practices
This first joint plan on One Health aims to create a framework to integrate systems and capacity so that we can collectively better prevent, predict, detect, and respond to health threats
The training center will focus on providing radiation oncologists, radiotherapy technologists, and medical physicists with the necessary skills
Periodic community awareness program through Aster’s DM Healthcare’s visual media and social media platforms and implementing TB control activity through Aster Pharmacies across South India
The hospital has taken a huge step by offering “Titli-palliative care services at home” to provide curative, restorative, and life-prolonging treatment to seriously ill children
Specialized cancer care will be offered to cancer patients making it accessible and affordable. We have adopted a patient-centric approach.
Ours is a story of India’s resilient public health system and of everyone working together as team India to battle the pandemic
Subscribe To Our Newsletter & Stay Updated
